Business Transformation Consulting
in Healthcare Providers

The short answer

Most attempts to restructure care delivery start with an external assessment that assumes the scale of the needed changes rather than testing whether the current attribution and episode costs can support the contracts already signed. The version of this question that applies to healthcare providers is not the generic one. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — so an answer that ignores cost per episode will be confidently wrong. The analysis has to start from payer mix and panel size rather than from revenue.

A transformation project combines assessing where margins are lost on attributed lives, selecting which panels or contracts to adjust, and staffing the operational shifts. Providers bundle these because the initial review is offered at low cost to define the scope of subsequent work, creating an incentive for findings that justify broad interventions across payer mix and panel operations.

Failure rates remain high because the conversion from contract terms to project plans bypasses the calculation of contribution per provider against cost per episode, leaving the sequence of changes unanchored to what actually determines contract performance.

The test is whether the CFO or medical director can already list the two or three adjustments to panel size or payer mix that would lift contribution, with the per-episode costs attached. If so, the issue is implementation capacity. If not, further spending on execution teams only deepens the mismatch between risk accepted and data available.

Corporate Strategy & Transformation produces the allocation of costs across the 38,000 attributed lives and identifies which contracts or panels are subsidizing others, without assuming delivery resources are required. When the arithmetic shows that external capacity is needed, it states the scope plainly, avoiding the first round of invoices that follow an untested assumption.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Contracts are described as covering attributed lives before episode-level costs have been calculated for those populations.
✓ A project charter outlines workstreams before any breakdown of contribution per provider exists.
✓ Workstreams are organized around clinical departments instead of around specific value-based contract shortfalls.

The move that usually makes it worse. Engaging the same firm for the initial review of cost per episode and payer mix that will later propose the volume of changes to be implemented.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and the word "transformation" is being used before anyone has agreed what is broken. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

What does business transformation consulting actually cost?

For a mid-market company the diagnostic phase alone is commonly £75k–£250k over six to ten weeks, and the delivery phase that follows is usually several multiples of that. Large-firm day rates run roughly £1,500–£3,500 for a consultant and £4,000–£8,000 for a partner, and a typical team blends the two so the effective rate lands somewhere in the middle. The number that matters is not the day rate, though — it is the ratio of diagnosis to delivery, because that is where the scope is set.

Can software replace a transformation consultancy?

No, and any tool that claims otherwise is selling you something. Software cannot run a programme office, hold a difficult conversation with a divisional MD, or supply forty people for nine months. What it can do is produce the analysis that decides whether you need those things, and what they should be pointed at — which is the part that is most often rushed and most expensive to get wrong.

How do we keep control of the scope?

Buy the diagnosis separately from whoever will deliver, and write the decision down before you take delivery bids. Once the two or three changes are named and the arithmetic is on paper, the delivery tender is a procurement exercise with a fixed brief. Once they are not, the tender sets its own brief, and it is always a larger one.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.